Veru Inc. Receives Regulatory Clarity for Enobosarm Phase 3 Trial, Boosting Prostate Cancer Treatment Prospects
Veru Inc. has announced regulatory clarity for its enobosarm Phase 3 trial, a significant development that could unlock new opportunities for growth and collaboration in the biopharmaceutical industry.
3 minutes to read